Fortrea Cash Flow Statement
FTRE / Health Care|5 years of annual SEC 10-K data (FY2021-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
Fortrea generated $114M in operating cash flow and $88M in free cash flow in FY2025. Free cash flow margin was 3.2% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income | -$986.2M | -$328.5M | -$25.2M | $186.2M | $98.0M |
| Depreciation & Amortization | $78.0M | $86.9M | $98.0M | $93.6M | $166.3M |
| Operating Cash Flow | $113.5M | $262.8M | $168.4M | $82.7M | $169.8M |
| Capital Expenditures | $25.2M | $25.5M | $40.3M | $54.4M | $26.5M |
| Free Cash Flow | $88.3M | $237.3M | $128.1M | $28.3M | $143.3M |
| FCF Margin | 3.2% | 8.8% | 4.5% | 1.0% | 4.7% |